• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国硬皮病研究小组的共识最佳实践路径:系统性硬化症的胃肠道表现

Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.

作者信息

Hansi Navjyot, Thoua Nora, Carulli Maresa, Chakravarty Kuntal, Lal Simon, Smyth Anita, Herrick Ariane, Ogunbiyi Olagunju, Shaffer Jon, Mclaughlin John, Denton Christopher, Ong Voon, Emmanuel Anton V, Murray Charles D

机构信息

Royal Free Hospital, London, UK.

出版信息

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-214-21. Epub 2014 Nov 5.

PMID:25372804
Abstract

Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.

摘要

系统性硬化症是一种自身免疫性结缔组织疾病,可呈进行性发展并累及多个系统。关于并发症管理的指导基于有限的数据集,临床医生的实践也存在差异。英国硬皮病研究小组设立了几个工作组,以就特定并发症的管理达成一些共识路径。大约十分之九的系统性硬化症患者会累及胃肠道系统,在这篇综述文章中,我们以基于症状的方法探讨这些并发症的管理。这些算法对临床医生是一个有用的工具,我们希望它将成为一个参考点,并突出这些领域进一步研究的必要性。

相似文献

1
Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.英国硬皮病研究小组的共识最佳实践路径:系统性硬化症的胃肠道表现
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-214-21. Epub 2014 Nov 5.
2
Current management of the gastrointestinal complications of systemic sclerosis.系统性硬化症的胃肠道并发症的当前管理。
Nat Rev Gastroenterol Hepatol. 2016 Aug;13(8):461-72. doi: 10.1038/nrgastro.2016.99. Epub 2016 Jul 6.
3
Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma.硬皮病患者的胃肠道表现、营养不良以及肠内和肠外营养的作用
J Clin Gastroenterol. 2015 Aug;49(7):559-64. doi: 10.1097/MCG.0000000000000334.
4
Systemic Sclerosis: Gastrointestinal Disease and Its Management.系统性硬化症:胃肠道疾病及其管理
Rheum Dis Clin North Am. 2015 Aug;41(3):459-73. doi: 10.1016/j.rdc.2015.04.007. Epub 2015 May 23.
5
Nutrition in systemic sclerosis.系统性硬化症中的营养
Reumatol Clin. 2012 May-Jun;8(3):135-40. doi: 10.1016/j.reuma.2011.09.006. Epub 2011 Dec 24.
6
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.高分辨率测压法与加利福尼亚大学洛杉矶分校硬皮病临床试验联盟 GIT 2.0 在系统性硬化症中的比较。
Semin Arthritis Rheum. 2017 Dec;47(3):403-408. doi: 10.1016/j.semarthrit.2017.05.005. Epub 2017 May 19.
7
[Gastrointestinal involvement in systemic sclerosis].[系统性硬化症中的胃肠道受累]
Presse Med. 2006 Dec;35(12 Pt 2):1952-65. doi: 10.1016/s0755-4982(06)74930-2.
8
[Gastrointestinal features in systemic sclerosis].[系统性硬化症的胃肠道特征]
Rev Med Suisse. 2014 Apr 16;10(426):860-3.
9
Systemic sclerosis and the gut.系统性硬化症与肠道。
Expert Rev Gastroenterol Hepatol. 2013 May;7(4):331-9. doi: 10.1586/egh.13.22.
10
[Digestive involvement of scleroderma].[硬皮病的消化系统受累]
Rev Prat. 2002 Nov 1;52(17):1896-900.

引用本文的文献

1
Drug treatment strategies for erosive esophagitis in adults: a narrative review.成人糜烂性食管炎的药物治疗策略:叙述性综述
Transl Gastroenterol Hepatol. 2025 Jul 23;10:54. doi: 10.21037/tgh-24-168. eCollection 2025.
2
Views of nutrition needs in patients with systemic sclerosis.系统性硬化症患者营养需求的观点。
J Scleroderma Relat Disord. 2024 Oct;9(3):216-222. doi: 10.1177/23971983241264868. Epub 2024 Aug 8.
3
Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review.
补充益生菌对系统性硬化症患者胃肠道并发症及生活质量的影响:一项系统评价。
Heliyon. 2024 Aug 13;10(16):e36230. doi: 10.1016/j.heliyon.2024.e36230. eCollection 2024 Aug 30.
4
The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes.胃食管反流病及其治疗对间质性肺病结局的影响。
Arthritis Res Ther. 2024 Jun 25;26(1):124. doi: 10.1186/s13075-024-03355-0.
5
Approach to esophageal absent contractility: can we do better?食管无收缩力的治疗方法:我们能做得更好吗?
Ann Gastroenterol. 2024 Mar-Apr;37(2):117-124. doi: 10.20524/aog.2024.0860. Epub 2024 Feb 13.
6
Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.系统性硬化症胃肠道表现的管理:一种基于机制的方法。
Expert Rev Clin Immunol. 2024 Jun;20(6):603-622. doi: 10.1080/1744666X.2024.2320205. Epub 2024 Feb 26.
7
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.质子泵抑制剂在系统性硬化症中的应用:优化胃食管反流病治疗的重新评估
Lancet Rheumatol. 2022 Nov;4(11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. Epub 2022 Jul 25.
8
A survey of Australian rheumatologists' perspectives of nutrition needs in systemic sclerosis.澳大利亚风湿病学家对系统性硬化症营养需求观点的调查
J Scleroderma Relat Disord. 2023 Oct;8(3):203-209. doi: 10.1177/23971983231185465. Epub 2023 Jul 6.
9
Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.尼达尼布治疗系统性硬化症相关间质性肺病患者的随机、安慰剂对照 SENSCIS 试验中的营养不良风险。
Arthritis Care Res (Hoboken). 2023 Dec;75(12):2501-2507. doi: 10.1002/acr.25176. Epub 2023 Aug 7.
10
Management of systemic sclerosis: British Society for Rheumatology guideline scope.系统性硬化症的管理:英国风湿病学会指南范围
Rheumatol Adv Pract. 2023 Mar 14;7(1):rkad022. doi: 10.1093/rap/rkad022. eCollection 2023.